ClinConnect ClinConnect Logo
Search / Trial NCT06793605

Community Burden of MG Infection

Launched by CHINESE UNIVERSITY OF HONG KONG · Jan 21, 2025

Trial Information

Current as of August 24, 2025

Recruiting

Keywords

Mycoplasma Genitalium Chlamydia Trachomatis Neisseria Gonorrhoeae Men Who Have Sex With Men

ClinConnect Summary

This clinical trial, called "Community Burden of MG Infection," is studying a type of sexually transmitted infection (STI) called Mycoplasma genitalium (MG) among men who have sex with men in Hong Kong. The goal is to understand how common this infection is and how it spreads in the community. The study involves two main parts: first, participants will complete an online survey and provide samples for lab testing; second, researchers will use computer models to simulate how MG infection spreads and how different testing and treatment strategies might work.

To be eligible for this trial, participants must be men aged 18 or older who have sex with men and live in Hong Kong. They should also be able to read and write in English or Chinese. During the study, participants can expect to fill out an online questionnaire, provide samples for testing, and take an HIV self-test. It's important to know that this trial is currently looking for volunteers to take part, and anyone who cannot give their consent will not be included.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • men who have sex with men aged 18 or above, normally living in Hong Kong, and could communicate in written and spoken English or Chinese
  • Exclusion Criteria:
  • cannot provide consent

About Chinese University Of Hong Kong

The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported